Pharmaceutical Executive-05-07-2009

News Analysis
Pharmaceutical Executive

May 07, 2009

As it readies submission for a once-weekly diabetes injectable, Amylin announces that it will trim 35 percent of its sales force and put focus on specialty physicians.

News Analysis
Pharmaceutical Executive

May 07, 2009

New prescriptions for antiviral treatments get huge boost due to H1N1 epidemic. Numbers exceed those seen during this year's influenza season, and the numbers are climbing.

News Analysis
Pharmaceutical Executive

May 06, 2009

As the economy continues to retract, fewer biotech companies are finding the funding they need to survive, driving more firms to sell or close shop.

News Analysis
Pharmaceutical Executive

May 06, 2009

Pharm Exec Europe's Gerhard Symons speaks to Andrew Jones, a senior pharmaceutical analyst with the firm, about the value of introducing a "risk radar" to your organization.